Pancreatic Cancer Research

ResearcherBoston UniversityActive in the last 2 years

László Czakó

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6331-0802; OpenAlex author ID A5011442364. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 10

  1. MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice. Co-author DOI 10.1159/000541874↗
  2. Importance of MUC17 in the bile-induced pancreatic cancer progression Co-author DOI 10.1016/j.pan.2023.06.769↗
  3. Bile accelerates carcinogenic processes in pancreatic ductal adenocarcinoma cells through the overexpression of MUC4. Co-author DOI 10.1038/s41598-020-79181-6↗
  4. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial. Last author DOI 10.1136/bmjopen-2020-037267↗
  5. Prospective comparison of slow-pull and standard suction techniques of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of solid pancreatic… Co-author DOI 10.1186/s12876-018-0921-9↗
  6. New-onset type 2 diabetes mellitus--A high-risk group suitable for the screening of pancreatic cancer? Last author DOI 10.1016/j.pan.2015.12.005↗
  7. A Common CCK-B Receptor Intronic Variant in Pancreatic Adenocarcinoma in a Hungarian Cohort. Co-author DOI 10.1097/mpa.0000000000000539↗
  8. Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group. Co-author DOI 10.15403/jgld.2014.1121.252.pcr↗
  9. [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Co-author DOI 10.1556/oh.2015.30063↗
  10. [Pancreatic cancer or autoimmune pancreatitis: endosonography as a diagnostic reviser]. Co-author DOI 10.1556/oh.2013.29513↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eleonóra Gál · 3 shared papers, 2020–2025 · strength 0.51
  2. Viktória Venglovecz · 3 shared papers, 2020–2025 · strength 0.51
  3. Zoltán Veréb · 3 shared papers, 2020–2025 · strength 0.51
  4. Péter Jenő Hegyi · 4 shared papers, 2015–2020 · strength 0.24
  5. Boshra Yosef · 1 shared paper, 2025 · strength 0.22
  6. Zoltán Szepes · 3 shared papers, 2013–2019 · strength 0.16
  7. Dóra Illés · 2 shared papers, 2016–2020 · strength 0.15
  8. Anita Balázs · 2 shared papers, 2016 · strength 0.09
  9. Zsuzsanna Kahán · 2 shared papers, 2016 · strength 0.09
  10. Miklós Sahin‐Tóth · 2 shared papers, 2015–2016 · strength 0.09
  11. Renáta Bor · 1 shared paper, 2019 · strength 0.08
  12. Richárd Szmola · 2 shared papers, 2015–2016 · strength 0.08
  13. Ákos Szűcs · 2 shared papers, 2015–2016 · strength 0.08
  14. Dezső Kelemen · 2 shared papers, 2015–2016 · strength 0.08
  15. Gábor Lakatos · 1 shared paper, 2016 · strength 0.04
  16. Ákos Pap · 1 shared paper, 2015 · strength 0.04
  17. Attila Oláh · 1 shared paper, 2015 · strength 0.04
  18. Tibor Wittmann · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.